Mycobacterium nucleic acidum et rifampicin (RIF) resistentia (Inh)

Short description:

Hoc ornamentum est usus pro in vitro qualitative deprehendatur Mycobacterium tuberculosis DNA in humana sputum, solidum culturae (LJ Medium) et Liquid Codon (81BP , Rifampicin resistentia determinandum regionem) de RPOB gene of Mycobacterium tuberculosis rifampicin resistance, as well as the mutations in the main mutation sites of Mycobacterium tuberculosis isoniazid resistance.It provides aid to the diagnosis of Mycobacterium tuberculosis infection, and it detects the main resistance genes of rifampicin and isoniazid, which helps to understand the drug resistance of Mycobacterium tuberculosis infectam a patientes estote.

Mitte inscriptio nobis

Product Detail

Product Tags

Product Name

HWTS-Rt147 Mycobacterium tuberculosis nucleic acidum et rifampicin (RIF), (Inh) Deprehensio Kit (Reliquit curva)

Epidemiology

Mycobacterium tuberculosis, paulo tuberculum Bacillus (TB), est in pathogenic Bacteria, quod causas tuberculosis, et currently, in communiter primo-linea anti-tuberculosis medicamentis includit, Rifampicin et Ethambutol, etc.^[I]. Tamen, propter falsa usum anti-tuberculosis medicamentis et characteres in cell murum structuram de Mycobacterium tuberculosis, Mycobacterium tuberculosis habet developed medicamento resistentia ad anti-tuberculosis medicamento, et praecipue periculosum formam est multidrug, repugnans tuberculosis (mdr- TB), quod repugnant duo maxime communia et efficax medicinae, rifampicin et isoniazid^[II].

Quaestionem tuberculosis medicamento resistentia existit in omnibus regionibus lustat a qui. Ut providere magis accurate treatment consilia ad tuberculosis aegris, necesse est deprehendere resistentia ad anti-tuberculosis medicamentis, praesertim rifamned resistentia, quae facta est diagnostic step suadetur per qui in curatione tuberculosis^[III]. Etsi inventa est rifampicin resistentia est fere equivalent ad inventionis de MDR-TB, nisi detecting RIFAMPICIN resistentia ignorat aegris cum Mono-repugnant inh (referendo ad isoniazid sed sensitivo ad RIFAMPIn) et Mono Rifampicin rifampicin), quae ducunt ad aegris subiecta irrationabilis initial curatio regimens. Ideo isoniazid et rifampicin resistentia Testings sunt minimum necessarios in omnibus Dr-TB control programs^[⁴^].

Technical parametri

Repono	≤, XVIII ℃
PLUTEUM-vitae	XII mensibus
Specimen Type	Sputum sample, solidum culturae (LJ Medium), liquida Culture (MGIT Medium)
CV	<5.0%
LOD	Lod de ornamentum ad detectam Mycobacterium tuberculosis est X bacteria / ml;Et Lod de ornamentum et detecting rifampicin fera genus et mutant type est CL bacteria / ml; Et Lod de ornamentum ad Detectionem Isoniazid Ferus et Mutant Type est CC bacteria / ml.
Specifica	I) Non est crucis reactionem cum per ornamentum ad deprehendere humana genomic DNA (500ng), altera XXVIII genera respiratoriorum pathogens, et XXIX genera non-tuberculous Mycobacteria, et XXIX types of non-tuberculous Mycobacteria (ut ostensum est in mensa III).II) Non est crucem reactionem cum per ornamentum ad deprehendere mutationem sites aliis medicamento, repugnant genes RIFAMMAMMIs et Isoniazid sensitive Mycobacterium tuberculosis (ut ostensum est in mensa IV).III) commune interceptionem substantiae in exemplaria ut probentur, ut rifampicin (9mg / l), isoniazid (12mg / l), amoxymetazoline (11mg / l), mupirocin / l), mupirocin / l), mupirocin / l), Mupirocin (l), Mu (1mg / l), Muprocin (1mg / l), Muzymetazoline (1mg / l), Mupirocin (L), Mupirocin (20mg / l), pyrazinamide (45mg / l): Zanamivir (0.5MG / L), Dexamethasone (20mg / L) Medicamenta, non effectum in ornamentum test results.
COMPRESSUS	Slan-96P Real-vicis PCR systems (Hongshi Medical Technology Co., Ltd.), BIOD CFX96 Real-vicis PCR ratio